Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity
暂无分享,去创建一个
C. Ries | A. Kiialainen | Sarah K. Hansen | M. Squadrito | D. Laoui | Danielle M. Thompson | M. D. Palma | C. Ooi | S. Hoves | Caroline Baer | Damya Laoui
[1] M. Roussel,et al. TNF Counterbalances the Emergence of M2 Tumor Macrophages. , 2015, Cell reports.
[2] C. Ries,et al. CSF-1/CSF-1R targeting agents in clinical development for cancer therapy. , 2015, Current opinion in pharmacology.
[3] S. Coffelt,et al. Immune-mediated mechanisms influencing the efficacy of anticancer therapies. , 2015, Trends in immunology.
[4] Mark Ibberson,et al. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. , 2014, Cell reports.
[5] Daehyun Baek,et al. mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues. , 2014, Molecular cell.
[6] T. Beißbarth,et al. Integrated miRNA and mRNA profiling of tumor‐educated macrophages identifies prognostic subgroups in estrogen receptor‐positive breast cancer , 2014, Molecular oncology.
[7] Michael C. Ostrowski,et al. CSF1-ETS2 Induced microRNA in Myeloid Cells Promote Metastatic Tumor Growth , 2014, Oncogene.
[8] Fei Wang,et al. Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma. , 2014, Journal of the National Cancer Institute.
[9] V. Kim,et al. Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.
[10] Jeffrey W Pollard,et al. Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.
[11] J. Blay,et al. Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. , 2014, Cancer cell.
[12] F. Baas,et al. Next-generation sequencing of microRNAs uncovers expression signatures in polarized macrophages. , 2014, Physiological genomics.
[13] Christina S. Leslie,et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression , 2013, Nature Medicine.
[14] L. Naldini,et al. A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice. , 2013, Blood.
[15] M. Pittet,et al. MicroRNA-mediated control of macrophages and its implications for cancer. , 2013, Trends in immunology.
[16] F. Marincola,et al. miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. , 2013, Immunity.
[17] F. Bazzoni,et al. Negative regulation of Toll-like receptor 4 signaling by IL-10–dependent microRNA-146b , 2013, Proceedings of the National Academy of Sciences.
[18] E. Abraham,et al. MicroRNA let-7c Regulates Macrophage Polarization , 2013, The Journal of Immunology.
[19] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[20] Thomas A. Wynn,et al. Macrophage biology in development, homeostasis and disease , 2013, Nature.
[21] C. Lewis,et al. Macrophage regulation of tumor responses to anticancer therapies. , 2013, Cancer cell.
[22] M. Glennie,et al. Agonistic CD40 Antibodies and Cancer Therapy , 2013, Clinical Cancer Research.
[23] G. Teng,et al. Let-7b Is Involved in the Inflammation and Immune Responses Associated with Helicobacter pylori Infection by Targeting Toll-Like Receptor 4 , 2013, PloS one.
[24] A. Mildner,et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.
[25] R. Sachidanandam,et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries , 2012, Nature Methods.
[26] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[27] David C. Smith,et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. , 2012, The New England journal of medicine.
[28] S. Erkeland,et al. Dicer1 deletion in myeloid-committed progenitors causes neutrophil dysplasia and blocks macrophage/dendritic cell development in mice. , 2012, Blood.
[29] Anton P. McCaffrey,et al. Identifying Functional MicroRNAs in Macrophages with Polarized Phenotypes* , 2012, The Journal of Biological Chemistry.
[30] Michael T. McManus,et al. A resource for the conditional ablation of microRNAs in the mouse. , 2012, Cell reports.
[31] Drew M. Pardoll,et al. The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.
[32] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[33] Alberto Mantovani,et al. Macrophage plasticity and polarization: in vivo veritas. , 2012, The Journal of clinical investigation.
[34] R. Lyle,et al. miR-511-3p modulates genetic programs of tumor-associated macrophages. , 2012, Cell reports.
[35] S. H. van der Burg,et al. Identification and manipulation of tumor associated macrophages in human cancers , 2011, Journal of Translational Medicine.
[36] Hyun Cheol Chung,et al. A Densely Interconnected Genome-Wide Network of MicroRNAs and Oncogenic Pathways Revealed Using Gene Expression Signatures , 2011, PLoS genetics.
[37] K. Plate,et al. Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion , 2011, The Journal of Immunology.
[38] L. O’Neill,et al. MicroRNAs: the fine-tuners of Toll-like receptor signalling , 2011, Nature Reviews Immunology.
[39] P. Carmeliet,et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. , 2011, Cancer cell.
[40] Michael T. McManus,et al. Analysis of microRNA knockouts in mice. , 2010, Human molecular genetics.
[41] A. Mantovani,et al. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.
[42] E. Lai,et al. Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis , 2010, Proceedings of the National Academy of Sciences.
[43] I. Campbell,et al. The Cell-Specific Induction of CXC Chemokine Ligand 9 Mediated by IFN-γ in Microglia of the Central Nervous System Is Determined by the Myeloid Transcription Factor PU.1 , 2010, The Journal of Immunology.
[44] P. De Baetselier,et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. , 2010, Cancer research.
[45] Todd R. Golub,et al. MicroRNA miR-125a controls hematopoietic stem cell number , 2010, Proceedings of the National Academy of Sciences.
[46] H. Fehling,et al. Dicer-Dependent MicroRNAs Control Maturation, Function, and Maintenance of Langerhans Cells In Vivo , 2010, The Journal of Immunology.
[47] Masaki Noda,et al. Osteoclast‐specific Dicer gene deficiency suppresses osteoclastic bone resorption , 2009, Journal of cellular biochemistry.
[48] A. Sica,et al. A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. , 2009, Blood.
[49] M. Hebbar,et al. Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophages , 2009, International journal of cancer.
[50] M. Tretiakova,et al. Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment. , 2009, Cancer research.
[51] M. Colonna,et al. DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors , 2008, The Journal of experimental medicine.
[52] Andrea Falini,et al. Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. , 2008, Cancer cell.
[53] B. Williams,et al. Mapping and quantifying mammalian transcriptomes by RNA-Seq , 2008, Nature Methods.
[54] G. Daley,et al. Selective Blockade of MicroRNA Processing by Lin28 , 2008, Science.
[55] Steven P. O'Hara,et al. A Cellular Micro-RNA, let-7i, Regulates Toll-like Receptor 4 Expression and Contributes to Cholangiocyte Immune Responses against Cryptosporidium parvum Infection* , 2007, Journal of Biological Chemistry.
[56] L. Luo,et al. A global double‐fluorescent Cre reporter mouse , 2007, Genesis.
[57] L. Zitvogel,et al. In vivo veritas , 2005, Nature Biotechnology.
[58] Luigi Naldini,et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.
[59] Michael T. McManus,et al. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[60] G. Trinchieri,et al. Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. , 2005, Cancer research.
[61] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[62] L. Naldini,et al. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.
[63] S. Elledge,et al. Dicer is essential for mouse development , 2003, Nature Genetics.
[64] Lloyd J. Old,et al. The roles of IFNγ in protection against tumor development and cancer immunoediting , 2002 .
[65] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[66] G. Freeman,et al. Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.
[67] W. Reith,et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.
[68] J. Finke,et al. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. , 1998, Journal of immunology.
[69] K. Movahedi,et al. Tissue-resident versus monocyte-derived macrophages in the tumor microenvironment. , 2016, Biochimica et biophysica acta.
[70] Robert Gentleman,et al. gCMAP: user-friendly connectivity mapping with R , 2014, Bioinform..
[71] Hiroaki Ikeda,et al. The roles of IFN gamma in protection against tumor development and cancer immunoediting. , 2002, Cytokine & growth factor reviews.
[72] L. Naldini,et al. Transduction of a gene expression cassette using advanced generation lentiviral vectors. , 2002, Methods in enzymology.